Paclitaxel reduces regulatory T cell numbers and inhibitory function and enhances the anti-tumor effects of the TLR9 agonist PF-3512676 in the mouse

By Vicari Alain  

Cancer Immunology, Immunotherapy, Vol. 58, Iss. 4, 2009-04 ,pp. : 615-628

Springer Publishing Company

Access to resources Recommend Favorite

Cytotoxic T lymphocyte-associated antigen 4 inhibition increases the antitumor activity of adoptive T-cell therapy when carried out with naïve rather than differentiated T cells

By                                

Oncology Reports, Vol. 33, Iss. 5, 2015-01 ,pp. : 2545-2552

Spandidos Publications

Access to resources Recommend Favorite

Myeloma skews regulatory T and pro-inflammatory T helper 17 cell balance in favor of a suppressive state

By Favaloro James   Brown Ross   Aklilu Esther   Yang Shihong   Suen Hayley   Hart Derek   Fromm Phillip   Gibson John   Khoo Liane   Ho P. Joy   Joshua Douglas  

Leukemia and Lymphoma, Vol. 55, Iss. 5, 2014-05 ,pp. : 1090-1098

Informa Healthcare

Access to resources Recommend Favorite

Substance P enhances the activation of AMPK and cellular lipid accumulation in 3T3L1 cells in response to high levels of glucose

By      

Molecular Medicine Reports, Vol. 12, Iss. 6, 2015-01 ,pp. : 8048-8054

Spandidos Publications

Access to resources Recommend Favorite

Recent Advances in T Cell Adoptive Immunotherapy of Cancer

By  

Current Cancer Therapy Reviews, Vol. 4, Iss. 1, 2008-02 ,pp. : 1-13

Bentham Science Publishers

Access to resources Recommend Favorite